Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3834
+0.0075 (2.00%)
Apr 28, 2025, 9:30 AM EDT - Market open
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $22.71 million as of April 28, 2025. Its market cap has decreased by -89.85% in one year.
Market Cap
22.71M
Enterprise Value
-39.79M
1-Year Change
-89.85%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $22.71M, a decrease of -93.78%. That is a compound annual growth rate of -51.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 22.26M | -33.07% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |